Trellus Health (TRLS) Competitors GBX 0.67 -0.03 (-4.29%) (As of 11:29 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors TRLS vs. IQAI, FDBK, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, and COGShould you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include IQ-AI (IQAI), Feedback (FDBK), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), and Cambridge Cognition (COG). These companies are all part of the "health information services" industry. Trellus Health vs. IQ-AI Feedback DeepVerge Sensyne Health EMIS Group Craneware Instem Kooth Renalytix Cambridge Cognition IQ-AI (LON:IQAI) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, community ranking, media sentiment, profitability, risk, dividends, earnings and institutional ownership. Which has more volatility & risk, IQAI or TRLS? IQ-AI has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500. Does the MarketBeat Community prefer IQAI or TRLS? IQ-AI received 6 more outperform votes than Trellus Health when rated by MarketBeat users. CompanyUnderperformOutperformIQ-AIOutperform Votes666.67% Underperform Votes333.33% Trellus HealthN/AN/A Does the media prefer IQAI or TRLS? In the previous week, IQ-AI's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score. Company Overall Sentiment IQ-AI Neutral Trellus Health Neutral Is IQAI or TRLS more profitable? Trellus Health has a net margin of 0.00% compared to IQ-AI's net margin of -77.52%. Trellus Health's return on equity of -35.08% beat IQ-AI's return on equity.Company Net Margins Return on Equity Return on Assets IQ-AI-77.52% -140.75% -22.03% Trellus Health N/A -35.08%-22.76% Do institutionals & insiders have more ownership in IQAI or TRLS? 19.3% of Trellus Health shares are held by institutional investors. 66.0% of IQ-AI shares are held by company insiders. Comparatively, 49.7% of Trellus Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, IQAI or TRLS? IQ-AI has higher revenue and earnings than Trellus Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIQ-AI£538.19K5.77N/AN/AN/ATrellus Health£35K30.92-£6.66M-£0.03-22.33 SummaryIQ-AI beats Trellus Health on 6 of the 10 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Trellus Health News Delivered to You Automatically Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRLS vs. The Competition Export to ExcelMetricTrellus HealthHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£1.08M£177.54M£5.10B£1.39BDividend YieldN/A6.51%5.04%11.86%P/E Ratio-22.33697.7695.621,573.12Price / Sales30.92311.141,217.19212,245.03Price / Cash0.7639.8439.5933.11Price / Book0.074.616.942.79Net Income-£6.66M-£7.17M£118.89M£154.04M7 Day Performance3.08%-1.22%-1.33%-0.59%1 Month Performance-0.74%1.31%-3.17%7.21%1 Year Performance-85.18%0.49%32.49%94.65% Trellus Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRLSTrellus HealthN/AGBX 0.67-4.3%N/A-85.3%£1.08M£35,000.00-22.3331IQAIIQ-AIN/AGBX 1.40+7.7%N/A-65.7%£3.10M£538,190.00-13.676FDBKFeedbackN/AGBX 20-2.4%N/A-72.7%£2.67M£1.18M-82.0024Gap DownDVRGDeepVergeN/AGBX 0.15flatN/AN/A£1.14M£12.41M-15.0073SENSSensyne HealthN/AGBX 0.35-33.3%N/A+0.0%£583,000.00£7.81M-0.0270Gap DownEMISEMIS GroupN/AGBX 1,920flatN/A+0.0%£1.23B£176.86M4,085.111,560CRWCraneware1.8347 of 5 starsGBX 2,220+0.5%GBX 2,700+21.6%+37.3%£784.55M£189.27M8,525.00734High Trading VolumeINSInstemN/AGBX 830flatN/A+0.0%£199.62M£61.63M5,928.57500KOOKooth1.9513 of 5 starsGBX 163-1.2%GBX 585+258.9%-45.0%£59.46M£54.17M1,375.00478RENXRenalytixN/AGBX 7.50-3.2%N/A-68.1%£12.45M£2.29M-30.00102News CoverageGap DownCOGCambridge CognitionN/AGBX 28.40+2.5%N/A-48.3%£11.91M£13.08M-710.0080 Related Companies and Tools Related Companies IQAI Competitors FDBK Competitors DVRG Competitors SENS Competitors EMIS Competitors CRW Competitors INS Competitors KOO Competitors RENX Competitors COG Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:TRLS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trellus Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trellus Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
